New Chairman of KPMA Stresses on R&D Investments and Activities

Published: 2005-03-15 06:56:00

Updated: 2005-03-15 06:56:00

The newly appointed Chairman Huh Il-sup of the Korea Pharmaceutical Manufacturers Association (KPMA) expressed in the interview held last week that, under his new leadership, KPMA will continue to focus on promoting an efficient R&D investment by both the government and the pharmaceutical firms.

Chairman Huh stated that the only way for the domestic firms to survive in the fiercely competiti...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.